HemaCare Co. (OTCMKTS:HEMA – Get Free Report)’s share price traded up 0.6% on Tuesday . The stock traded as high as $25.31 and last traded at $25.31. 5,400 shares traded hands during mid-day trading, a decline of 86% from the average session volume of 39,950 shares. The stock had previously closed at $25.16.
HemaCare Price Performance
The business has a 50-day simple moving average of $25.31 and a 200-day simple moving average of $25.31.
About HemaCare
HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy.
Featured Articles
- Five stocks we like better than HemaCare
- How to Read Stock Charts for Beginners
- Palantir Cracks $50, Is There Still Time to Get on Board?
- The How And Why of Investing in Oil Stocks
- Insider Buying Signals Upside for These 3 Stocks
- Energy and Oil Stocks Explained
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Receive News & Ratings for HemaCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HemaCare and related companies with MarketBeat.com's FREE daily email newsletter.
